Bollard Group’s Novartis NVS Stock Holding History

Bollard Group’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-79	Closed	-$8K	–	318
2023 Q3	$8K	Hold	79	–	–	﹤0.01%	278
2023 Q2	$8K	Buy	+79	New	+$7.9K	﹤0.01%	324
2022 Q2	–	Sell	-1,175	Closed	-$103K	–	368
2022 Q1	$103K	Buy	1,175 +29	+3%	+$2.51K	﹤0.01%	285
2021 Q4	$100K	Hold	1,146	–	–	﹤0.01%	291
2021 Q3	$94K	Hold	1,146	–	–	﹤0.01%	288
2021 Q2	$105K	Hold	1,146	–	–	﹤0.01%	282
2021 Q1	$98K	Hold	1,146	–	–	﹤0.01%	282
2020 Q4	$108K	Hold	1,146	–	–	﹤0.01%	259
2020 Q3	$100K	Hold	1,146	–	–	﹤0.01%	245
2020 Q2	$100K	Buy	+1,146	New	+$98.9K	﹤0.01%	250

Other funds holding NVS

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bollard Group's NVS Position: Q4 2023 in Review

Bollard Group sold out of Novartis (NVS) in Q4 2023, closing a stake of 79 shares — an estimated $8K sold.

Bollard Group first reported a position in NVS in Q2 2020 and held it in 10 quarters. The position peaked at $108K in Q4 2020. 1,272 funds tracked by Wall St. Rank hold NVS as of Q4 2023.

Bollard Group reported no remaining Novartis position as of Q4 2023 after selling out during the quarter.
Bollard Group sold 79 Novartis shares in Q4 2023, an estimated $8K.
Bollard Group first reported a position in Novartis in Q2 2020 and held it in 10 quarters.
Bollard Group's Novartis position peaked at $108K in Q4 2020.
1,272 funds tracked by Wall St. Rank held Novartis as of Q4 2023.

Based on Bollard Group's 13F filing for Q4 2023, filed 13 Feb 2024.